We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAT:NYSENordic American Tankers Limited Analysis

Data as of 2026-04-19 - not real-time

$6.03

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nordic American Tankers is trading at $6.03, comfortably above its near‑term support of $5.21 and riding a bullish price trend (20‑day SMA $5.79 > 50‑day SMA $5.36 > 200‑day SMA $3.86). The RSI sits at ~60, suggesting modest upside momentum, but the MACD histogram is negative and the signal line is bearish, highlighting short‑term pressure. Fundamentally, the company is **severely overvalued** with a trailing P/E of ~100 versus an industry average of 21, while revenue has collapsed by 66% and debt ($424 M) dwarfs cash ($45 M), resulting in a negative free cash flow position. The dividend yield is attractive at 7.8%, yet the payout ratio is only 6% of earnings, raising questions about sustainability given the weak cash generation.
Recent news points to a $40 M sale of an older tanker and management’s optimism about fleet growth, complemented by an analyst’s upgrade to a $7.50 price target. However, these positive catalysts must be weighed against the high leverage, thin profit margins, and the current overvaluation, suggesting a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with bullish SMA alignment
  • Bearish MACD signal indicating near‑term downside risk
  • High valuation relative to peers

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential fleet expansion from recent vessel sale
  • Forward P/E around 22 aligns with industry norms
  • High dividend yield offering income while earnings improve

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated debt load and negative free cash flow
  • Cyclical exposure of the tanker and energy midstream sector
  • Current overvaluation may limit upside despite dividend appeal

Key Metrics & Analysis

Financial Health

Revenue Growth-65.60%
Profit Margin6.69%
P/E Ratio100.5
ROE2.57%
ROA2.16%
Debt/Equity95.20
P/B Ratio2.9
Op. Cash Flow$19.8M
Free Cash Flow$-133777504
Industry P/E21.2

Technical Analysis

TrendBullish
RSI59.6
Support$5.21
Resistance$6.34
MA 20$5.79
MA 50$5.36
MA 200$3.86
MACDBearish
VolumeStable
Fear & Greed Index90.21

Valuation

Target Price$6.25
Upside/Downside3.65%
GradeOvervalued
TypeValue
Dividend Yield7.79%

Risk Assessment

Beta0.25
Volatility51.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.